Actively Recruiting
Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery
Led by Guangdong Provincial People's Hospital · Updated on 2024-08-15
375
Participants Needed
1
Research Sites
1356 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to present our center's experience in managing postoperative tricuspid valve regurgitation over the past 25years and to analyze the outcomes of these surgical treatments.
CONDITIONS
Official Title
Surgical Treatments of Tricuspid Valve Regurgitation After Cardiac Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who had surgical treatment for tricuspid valve disease following cardiac surgery from 1999 to 2023
- Patients aged 16 years or older
You will not qualify if you...
- Patients younger than 16 years old
- Severe tricuspid valve leakage caused by primary pulmonary hypertension
- Cases with substantial missing medical data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University
Guangzhou, Guangdong, China, 510080
Actively Recruiting
Research Team
H
Huanlei Huang
CONTACT
Y
Yingjie Ke
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here